Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-MX-13
Country
MX
Application Type
National Stage
Patent Status
Issued
Patent Number
Publication Number
Application Number
MX/a/2016/007726
IC
NCI
Date Filed
Date Issued
Patent PDF